Live from the NIH registry
Studies recruiting near Ocala right now
Top 25 of 135 recruiting studies, sorted by proximity — each links to its official registry page
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — Ocala, Florida (0.9 mi)
· Sponsor: GlaxoSmithKline
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
Non-small Cell Lung Cancer, Melanoma
Phase 1
Interventional 174 participants sought
Ocala Oncology — Ocala, Florida (0.9 mi)
· Sponsor: Shanghai Henlius Biotech
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Florida Retina Institute Wildwood — Wildwood, Florida (22.6 mi)
· Sponsor: Boehringer Ingelheim
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Melanoma, Non-small Cell Lung Cancer
Phase 2
Interventional 178 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Ocala, Florida (0.9 mi)
· Sponsor: Akero Therapeutics, Inc
FX Shoulder Solutions Retrospective / Prospective Clinical Study
Rotator Cuff Syndrome of Shoulder and Allied Disorders, Osteoarthritis Shoulder
N/A
Observational 600 participants sought
Advanced Orthopedics Institute — The Villages, Florida (20.4 mi)
· Sponsor: FX Shoulder Solutions
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 2
Interventional 360 participants sought
Charter Research - The Villages /ID# 282376 — The Villages, Florida (20.4 mi)
· Sponsor: AbbVie
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 410 participants sought
Local Institution - 1027 — Ocala, Florida (0.9 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida (22.7 mi)
· Sponsor: Eli Lilly and Company
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — The Villages, Florida (20.4 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Ocala, Florida (0.9 mi)
· Sponsor: AstraZeneca
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Renstar Medical Research - Ocala - Northeast 1st Avenue- Site Number : 8400021 — Ocala, Florida (0.9 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida (22.7 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Renstar Medical Research — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
Healthy Participants, Dyslipidemia
Phase 1
Interventional 136 participants sought
Research Site — Inverness, Florida (26.0 mi)
· Sponsor: AstraZeneca
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Phase 1
Interventional 240 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Tizona Therapeutics, Inc
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
K2 Medical Research — Lady Lake, Florida (22.7 mi)
· Sponsor: Lantheus Biosciences Ltd.
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM)
Phase 1
Interventional 258 participants sought
Ocala Oncology Center — Ocala, Florida (0.9 mi)
· Sponsor: Shanghai Henlius Biotech
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Hypercholesterolemia
Phase 2
Interventional 420 participants sought
K2 Medical Research The Villages — The Villages, Florida (20.4 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Phase 3
Interventional 520 participants sought
GSK Investigational Site — Lady Lake, Florida (22.7 mi)
· Sponsor: GlaxoSmithKline
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Agitation, Alzheimer Disease
Phase 2
Interventional 120 participants sought
Charter Research - Lady Lake — The Villages, Florida (20.4 mi)
· Sponsor: Celgene
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Phase 3
Interventional 426 participants sought
Local Institution - 1608 — Ocala, Florida (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Nature Coast Clinical Research — Inverness, Florida (26.0 mi)
· Sponsor: Janssen Research & Development, LLC
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Ocala, Florida (0.9 mi)
· Sponsor: DalCor Pharmaceuticals